Castle Biosciences, Inc. (NAS: CSTL) Stock Analysis & Fundamentals | ScreenerHero

Create free account

CSTLCastle Biosciences, Inc.

NAS · US · Healthcare · Diagnostics & Research · castlebiosciences.com

23.85USD-1.93%Mkt Cap: 723.37M $P/E: —1d ago

Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), atopic dermatitis (AD), and uveal melanoma. The compan…

Industry Peers

Diagnostics & Research

vs Diagnostics & Research

P/B

Cheaper

1M Perf

Lower

Thermo Fisher Scientific Inc.

$186.32BUSDP/E 27.6

Danaher Corporation

$134.82BUSDP/E 36.8

$43.51BUSDP/E 42.0

IDEXX Laboratories, Inc.

$41.53BUSDP/E 38.7

Agilent Technologies, Inc.

$37.53BUSDP/E 26.7

Waters Corporation

$36.82BUSDP/E 47.7

IQVIA Holdings Inc.

$32.25BUSDP/E 24.0

$26.60BUSDP/E 31.9

Mettler-Toledo International Inc.

$25.82BUSDP/E 30.0

Quest Diagnostics Incorporated

$23.46BUSDP/E 23.4

Labcorp Holdings Inc.

$22.96BUSDP/E 24.8

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.12BUSDP/E 33.3

Eurofins Scientific SE

$12.91BUSDP/E 26.9

$12.41BUSDP/E 53.5

Charles River Laboratories International, Inc.

bioMérieux S.A.

$8.81BUSDP/E 20.6

Twist Bioscience Corporation

BillionToOne, Inc.

$5.52BUSDP/E 222.2

Sotera Health Company

$5.06BUSDP/E 43.3

$4.69BUSDP/E 54.4

DiaSorin S.p.A.

$3.65BUSDP/E 25.7

Adaptive Biotechnologies Corporation

GeneDx Holdings Corp.

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.48BUSDP/E 37.4

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Personalis, Inc.

OPKO Health, Inc.

Clínica Baviera, S.A.

$1.01BUSDP/E 21.1

$615.20MUSDP/E 40.1

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$297.38MUSDP/E 3.0

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Eurofins-Cerep SA

$94.30MUSDP/E 18.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

$10.07MUSDP/E 63.2

ENDRA Life Sciences Inc.

Proteome Sciences plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Oxford BioDynamics Plc

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap723.37M $

Enterprise Value498.41M $

Revenue (TTM)339.92M $

Gross Profit273.20M $

Net Income (TTM)-24.16M $

Revenue/Share11.60 USD

Last Price23.85 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees942

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-25.55

PEG—

EV/EBITDA-27.16

EV/Revenue1.47

P/S2.13

P/B1.57

EPS (TTM)-0.42

EPS (Forward)-0.93

52W Range

14.5931% of range44.28

52W High44.28 USD

52W Low14.59 USD

Profitability

Gross Margin79.37%

Oper. Margin-22.00%

EBITDA Margin-5.40%

Profit Margin-7.02%

ROE-5.13%

ROA-4.18%

Growth

Revenue Growth-4.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF64.35M $

CapEx (TTM)36.02M $

FCF Margin3.79%

FCF Yield1.78%

Net Debt-224.96M $

Net Debt/EBITDA12.26

Balance Sheet

Debt/Equity0.08

Current Ratio6.75

Quick Ratio6.26

Book Value/Sh15.23 USD

Cash/Share8.628 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.0 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)43.56 USD

Upside (mean)+82.6%

Target Range35.00 USD – 52.00 USD

$35.00+82.6% to mean$52.00

# Analysts9

Ownership

Shares Out.30.33M

Float26.78M

Insiders2.73%

Institutions92.98%

Short Interest

Short Ratio4.3d

Short % Float5.01%

Short % Out.4.90%

Shares Short1.49M

Short (prev mo.)1.42M

Technical

SMA 5021.78 (+9.5%)

SMA 20028.68 (-16.8%)

Beta1.02

S&P 52W Chg20.05%

Avg Vol (30d)323.69K

Avg Vol (10d)463.76K

Technical Indicators

RSI (14)64.1

MACD0.6086

MACD Signal0.1551

MACD Hist.+0.4535

BB Upper24.17 USD

BB Middle21.47 USD

BB Lower18.78 USD

BB Width25.08%

ATR (14)0.9954 USD

Vol Ratio (20d)0.97x